KBB Medic AS
ASActiveOrg 912372022Thormøhlens Gate 51, 5006 BergenComputer consultancy and computer facilities management activities· NACE 6220Est. 2013 · 13 years old0 employeeshttps://kbbmedic.no
Loading company…
Overview
KBB Medic AS is a Norwegian AS based in Bergen, operating in the Computer consultancy and computer facilities management activities sector. Incorporated in 2013, the company has 0 employees and reported revenue of NOK 2.9m in its latest annual filing.
Revenue 2025
2.9M NOK
+10% vs 2024
EBITDA margin
11.3 %
+152% vs 2024
Net profit 2025
0.4M NOK
+167% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
100.0 %
Very strongAmong the 20% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
0.0×
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
9.6 %
StrongAmong the 40% highest rated companies in the industry
20212025
EBITDA — year on year
NOK thousandsKey figures
Annual report 2025| Revenue | 2.9M NOK | +10% |
| EBITDA | 0.3M NOK | +152% |
| Net profit | 0.4M NOK | +167% |
| Total assets | 4.4M NOK | +26% |
| Equity | 4.4M NOK | +11% |
| Employees | 0 | — |
Company information
Legal name
KBB MEDIC AS
Org number
912372022
Legal form
Aksjeselskap
Founded
1 July 2013 · 13 years
Share capital
NOK 39,000
Employees
0 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Å utvikle plattformer for helseinformasjon, herunder websider, applikasjoner for telefon og nettbrett, websider, samt utføre tjenester og annen virksomhet som står i naturlig forhold til dette slik som f.eks undervisningsoppdrag.
(no translation available)
Contact
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), KBB Medic AS reported revenue of NOK 2.9m, an increase of 10% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 419.0k, and the EBITDA margin stood at 11.3%.
At the end of 2025, equity financed 100% of the balance sheet.
Financials
Revenue
NOK thousandsEBITDA
NOK thousandsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2,880 | 2,630 | 2,286 | 114 | 203 |
| Staff expenses | -0 | -0 | -0 | -6 | -0 |
| EBITDA | 324 | -627 | -404 | -367 | -246 |
| Depreciation & amort. | -30 | -20 | -20 | -20 | -98 |
| EBIT | 294 | -648 | -424 | -388 | -344 |
| Net financials | 125 | 21 | 13 | 1 | -0 |
| Profit before tax | 419 | -627 | -411 | -387 | -344 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 419 | -627 | -411 | -387 | -344 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4,374 | 3,483 | 4,522 | 4,853 | 539 |
| Equity | 4,374 | 3,955 | 4,507 | 4,918 | 599 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | -472 | 16 | -80 | -75 |
| Total debt | 0 | -472 | 16 | -80 | -75 |
Financial ratios
5-year trendEBITDA margin
11.3 %
20212025
Equity ratio
100.0 %
Very strongAmong the 20% highest rated companies in the industry
20212025
Return on equity
9.6 %
AverageAround the average of companies in the same industry
20212025
Net profit margin
14.5 %
StrongAmong the 40% highest rated companies in the industry
20212025
Asset turnover
0.66×
AverageAround the average of companies in the same industry
20212025
Debt / equity
0.00×
20212025
Sector performance
17 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 10% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginStrong
Among the 40% highest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginStrong
Among the 40% highest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Strong
Among the 40% highest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Strong
Among the 30% highest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery strong
Among the 10% highest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalStrong
Among the 40% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 30% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Debt & solvency
Solidity ratioVery strong
Among the 20% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Liabilities to equityVery strong
Among the 10% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest coverageVery strong
Among the 20% highest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Debt ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Income to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest rate on debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery strong
Among the 20% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 40% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RP Deputy Member | Deputy Member | 2019 |
BK Chief Executive Officer | Chief Executive Officer | 2013 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
KY Board of Directors | Board of Directors | 2019 |
SA Board of Directors | Board of Directors | 2019 |
BB Chairman | Chairman | 2019 |
BK Board of Directors | Board of Directors | 2019 |
EW Board of Directors | Board of Directors | 2021 |
Former (1)
KM Board of Directors | Board of Directors | 2019 – 2021 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 23.15% | 23.15% | 2024 | |
| Company | 23.15% | 23.15% | 2024 | |
| Company | 17.81% | 17.81% | 2024 | |
| Company | 13.62% | 13.62% | 2024 | |
| Individual | 7.72% | 7.72% | 2024 | |
Pascal Bircher | Company | 4.93% | 4.93% | 2025 |
| Individual | 2.67% | 2.67% | 2024 | |
| Individual | 2.67% | 2.67% | 2024 | |
| Individual | 1.13% | 1.13% | 2024 | |
| Individual | 0.91% | 0.91% | 2024 | |
Pascal Bircher | Company | 4.93% | 4.93% | 2024 |
| Individual | 2.71% | 2.71% | 2022 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Codelab Bergen As17.8062%Bigb Holding As23.148%Smallb Holding As23.148%Dalseide & Fløysand As13.6164%Pascal Bircher4.93%
KBB Medic AS (this company)Board network connections
Board members of KBB Medic AS also hold positions in 112 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svein Aaser | Board of Directors | 57 companiesMany roles |
| Ruben Patel | Deputy Member | 14 companiesMany roles |
| Karl-Erik Moberg | Board of Directors | 14 companiesMany roles |
| Bjarte Kjell Nore | Chief Executive Officer | 10 companiesMany roles |
| Kjell Yngvard Garatun-Tjeldstø | Board of Directors | 8 companiesMany roles |
| Bernt Bøgvald Aarli | Chairman | 7 companiesMany roles |
| Eirunn Waatevik Saure | Board of Directors | 2 companies |
Frequently asked questions
What is the Org number of KBB Medic AS?
KBB Medic AS is registered with Brønnøysundsregistrene under Org 912372022.
What is the revenue of KBB Medic AS?
KBB Medic AS reported revenue of NOK 2.9m in 2025.
Who is the CEO of KBB Medic AS?
Bjarte Kjell Nore is the CEO of KBB Medic AS.
Who is the chairman of KBB Medic AS?
Bernt Bøgvald Aarli chairs the board of KBB Medic AS, in role since 2019.
Where is KBB Medic AS headquartered?
KBB Medic AS's registered address is Thormøhlens Gate 51.